2022 American Transplant Congress

June 4-8, 2022 in Boston, MA

The ATC program is built in the Eastern Time Zone.

View by Title View Sessions View Topics

View by Date

Monday, June 6, 2022

7:00pm-8:00pm: Single Dose Alemtuzemab Provides Comparable Rejection Free and Infection Free Survival Compared to Double Dose Alemtuzumab. In Comparison to Alemtuzemab, Basiliximab Has Superior Infection Free Graft Survival. Results from a Steroid Sparing Transplant Group

H. Sharma, A. Odugoudar, B. Devkaran, A. Rao, A. El-Bakry, T. Gunawardhane, D. Ridgway, M. Howse, S. Mehra

Kidney Immunosuppression: Induction Therapy • Hynes Halls C & D

7:00pm-8:00pm: Single Port Robotic Extraperitoneal Kidney Transplantation: Technical Aspects

A. Kaviani, J. Kaouk, M. Abou Zeinab, A. Beksac, E. Ferguson, Y. Lin, D. Goldfarb, A. Wee, M. Eltemamy

Surgical Issues (Open, Minimally Invasive): All Organs • Hynes Halls C & D

7:00pm-8:00pm: Single-Cell Multiomics Defines Tolerogenic Extrathymic Aire-Expressing Cells

A. R. Gupta¹, J. Wang², C. Lareau³, I. Sun², J. Bautista¹, J. Gardner¹

Treg/Other Regulatory Cell/Tolerance • Hynes Halls C & D

7:00pm-8:00pm: Single-Cell RNA Sequencing Identifies the Changes of Human Normal Kidney After Transplantation

G. Huang¹, H. Zhang¹, X. Chen¹, G. Zhao¹, J. Luo¹, S. Yang², J. Qiu¹

Biomarkers: -omics and Systems Biology • Hynes Halls C & D

7:00pm-8:00pm: Sleeve Gastrectomy Reduces Need for Liver Transplantation for NASH Patients

R. A. Choudhury¹, A. Rouhi², G. Hoeltzel³, Y. Bababekov¹, A. Suarez-Pierre⁴, A. Yule¹, N. Vigneshwar⁴, N. Williams⁵, K. Dumon², J. Pomposelli¹, H. B. Moore¹, E. Pomfret¹, T. Nydam¹

Liver: Pediatrics • Hynes Halls C & D

7:00pm-8:00pm: Specificity and Avidity of Donor MHC-Specific B Cells in Naive, Rejecting and Tolerant Mice

I. Sayin¹, S. Khiew², D. Yin¹, P. Sage³, C. B. Cavazzoni³, R. King⁴, A. Chong¹

B-cell / Antibody /Autoimmunity • Hynes Halls C & D

7:00pm-8:00pm: Spectrum of Pre-Transplant Esophagram Abnormalities and Association with Long-Term Outcomes

I. Lill¹, D. Lovin², A. C. Lawrence², M. Mohanka², J. Joerns², S. Bollineni², I. L. Timofte², V. Kaza², M. Wait³, F. Torres², A. Banga²

Lung Transplantation • Hynes Halls C & D

7:00pm-8:00pm: Standard Induction with Basiliximab versus no Induction in Low Immunological Risk Kidney Transplant Recipients: Study Protocol for a Randomized Controlled Trial

A. Ajlan¹, H. Aleid¹, T. Ali¹, H. Joharji¹, Z. Alabdulkarim¹, T. Aburiash¹, K. Almeshari¹, A. Nazmi¹, Y. Shah¹, E. Devol¹, D. Alkortas¹, D. Broering¹, I. Alahmadi¹, A. Ullah¹, A. Alotaibi¹, A. Aljedai²

Kidney Immunosuppression: Induction Therapy • Hynes Halls C & D

7:00pm-8:00pm: Suppressive Effect of De Novo Everolimus on Primary Cytomegalovirus Infection in Kidney Transplant Recipient

S. Harada¹, H. Sasaki², Y. Takada², D. Takamoto², H. Harada², T. Hirano², H. Tanaka¹

Kidney Immunosuppression: Induction Therapy • Hynes Halls C & D

7:00pm-8:00pm: Sustained Alloantigen Exposure Reinforces Transplantation Tolerance

J. B. Allocco¹, C. McIntosh¹, P. Wang¹, Y. Wang¹, M. Miller¹, H. Sattar², D. Yin³, Z. J. Zhang⁴, A. Chong³, M. Alegre¹

Immunosuppression & Tolerance: Preclinical & Translational Studies • Hynes Halls C & D